To accelerate discovery, scientists from ATCC and the Broad Institute collaborated to engineer a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.
Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...
Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...
A skin cancer diagnosis can seem to arrive out of nowhere. But buried in years of health records, prescription histories, and ...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results